Proactive Investors - Run By Investors For Investors
Why invest in WRLD.U?
ICC International Cannabis Corp.: DEEP DIVE
OVERVIEW

ICC International Cannabis is growing a worldwide cannabis cultivation and lifestyle brand

The company plans to leverage its portfolio of brands as well as its distribution network of more than 39,000 European pharmacies to maximize margins and profitability
cannabis leaf
OVERVIEW: WRLD.U The Big Picture
ICC specializes in the acquisition and operation of international cannabis assets
  • The Vancouver-based company has cultivation, extraction, formulation and distribution assets woldwide

  • ICC markets and sells CBD products derived from Swiss, German, Serbian and Croatian industrial hemp inventories

  • The company also builds and operates high-quality, low-cost cannabis production, processing and distribution facilities

  • It has extensive agreements to cultivate and distribute cannabis and CBD products


ICC International Cannabis Corp (CSE:WRLD) (OTCMKTS:KNHBF) is on a clear path to be the first publicly listed, globally focused, pure cannabis play.

With a diversified portfolio of subsidiaries, the Vancouver-based company has cultivation, extraction, formulation and distribution assets in the UK, Denmark, Poland, Switzerland, Germany, Macedonia, Bulgaria, Greece, Italy, Portugal, Malta, Colombia, Argentina, Australia, South Africa and Lesotho.

Besides acquiring cultivation and distribution assets, ICC markets and sells CBD products derived from its Swiss, German, Serbian and Croatian industrial hemp inventories, and reaps the benefits of its 2019 cannabis production from key licenses in the European Union.

It plans to leverage its portfolio of brands as well as its distribution network of more than 39,000 European pharmacies to maximize margins and profitability.

The company also builds and operates high-quality, low-cost cannabis production, processing and distribution facilities worldwide.

ICC continues to grow with extensive agreements to cultivate and distribute cannabis and CBD products. A major goal is to inspire holistic wellness through the design, development and production of innovative and high-performing cannabis products and facilities.

Making deals

In April, ICC acquired nearly half of Wayland Group Corp’s (CSE:WAYL) (OTCMKTS:MRRCF) international assets and license portfolio.

Over three years, Wayland will supply ICC with 10,000 kg annually of dried cannabis flower grown at Wayland’s Langton, Ontario production facility. The cannabis will be distributed across medical cannabis markets in Europe and is expected to pay ICC more than 8 euros per gram.

ICC is also establishing itself as a brand leader, forging a licensing deal with Authentic Brands Group to market and distribute cannabidiol-derived health and wellness products throughout Europe under the Marilyn Monroe, Elvis Presley, Greg Norman, Tretorn, Aeropostale, and Frederick’s of Hollywood brands.

The company has steadily expanded its portfolio while continuing to evaluate potential cannabis and CBD-centric assets in a variety of high-growth jurisdictions, including Uruguay, Portugal, Malta, Costa Rica, Seychelles and Switzerland.

Inflection points

ICC is highly focused on a large and undeveloped emerging market for CBD in Europe, estimated to be worth C$66.8 billion by 2020.

Because European governments were early adopters of CBD, CBD is readily available as an over-the-counter product, stocked in local pharmacies and available online. ICC estimates product demand to outstrip supply by 5 to 1.

Auxly Cannabis Group Inc (TSV:XLY) has invested $5 million into ICC through convertible debentures, effectively expanding the reach of both companies to 22 countries across five continents.

Milestones

  • 35,000 kg three-year EU-GMP medical cannabis import agreement with Wayland group
  • 2,400 kg of CBD isolate produced in 2018
  • 50,000 kg of CBD isolate in 2019
  • More than 2,700 cannabis strains
  • 80,000 retail outlets, pharmacies and stores
  • 19 licenses for cultivation on four continents
  • 740,000 kg of forecasted dried cannabis production from outdoor cannabis cultivation

What the CEO says

To steer global growth, longtime cannabis executive David Shpilt was named CEO in April, replacing Eugene Beukman, who shifted to a seat on the board.

Shpilt spoke bullishly about his future at ICC, saying: “Together with International Cannabis, I look forward to the continued enhancement of excellence in cannabis, lifestyle, health care and design.”

 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full WRLD.U profile View Profile

ICC International Cannabis Corp. Timeline

Related Articles

medicinal cannabis concept
January 30 2019
Zelda has released its December quarterly report confirming multiple trials are on track.
windmill
May 07 2019
TGOD has been busy building out its facilities in Ontario, Quebec, and Jamaica and expects to reach combined production of 219,000 kilograms of cannabis around 2021
cannabis plant
December 14 2018
The Vancouver-based cannabis group services medical and recreational cannabis markets in Canada and internationally
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use